The Impact of MOUD Initiation in Patients with Injection Drug Use-Associated Infective Endocarditis
Clicks: 1
ID: 313394
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #98 of 208 articles by views in Open forum infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 208 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract This single-center retrospective study evaluated 218 patients with injection drug use-associated infective endocarditis, 169 of whom received medications for opioid use disorder (MOUD). Initiation of MOUD was associated with a non-significant increase in completion of antibiotic treatment and a significant reduction in 30-day post-discharge mortality, but not 90-day mortality.
| Reference Key |
openalex_W7161376741
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Seth Losiewicz, Bennett Collis, Sami El-Dalati, Evan Hall, Chloe Cao, Meredith Johnson, Takaaki Kobayashi, Bobbi Jo Stoner, Daniel Weaver |
| Journal | Open forum infectious diseases |
| Year | 2026 |
| DOI |
10.1093/ofid/ofag288
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.